{"id":"W4399281491","doi":"10.1200/jco.2024.42.16_suppl.10036","title":"Type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma (pLGG): Reversible decreases in growth velocity in the phase 2 FIREFLY-1 trial.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Glioma; Oncology; Gastroenterology; Cancer research; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005936654,0.0004015576,0.0005251209,0.0001415372,0.0001069578,0.0003965733,0.0002424364,0.0002645752,0.002015179],"category_scores_gemma":[0.0005695427,0.0001187735,0.0005849369,0.0001502323,0.00019645,0.0002558573,0.0001770518,0.001085788,0.000272061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006555329,"about_ca_system_score_gemma":0.0007312765,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001033577,"about_ca_topic_score_gemma":0.005612279,"domain_scores_codex":[0.9998543,0.00006242682,0.00000764379,0.00002093359,0.00002257769,0.000032166],"domain_scores_gemma":[0.9998502,0.00003026453,0.00004083926,0.000008978659,0.000009443517,0.00006031578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.398989,0.01017033,0.03065325,0.003152412,0.002944597,0.000918774,0.0005028729,0.004695493,0.04116841,0.001214304,0.02586609,0.4797245],"study_design_scores_gemma":[0.5058991,0.3679478,0.06751069,0.0005063912,0.002100404,0.004032807,0.0003229509,0.005296233,0.01639344,0.001120651,0.02880708,0.00006242499],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894983,0.005817278,0.0003063243,0.0005407445,0.0000923951,0.0003640417,0.0008505097,0.00006779229,0.002462762],"genre_scores_gemma":[0.992403,0.002825903,0.0008554162,0.0004573481,0.00005528528,0.0003381708,0.001611908,0.00001664956,0.001436369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002015179,"threshold_uncertainty_score":0.006741405,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09920939744627026,"score_gpt":0.4479339066055135,"score_spread":0.3487245091592432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}